Identification of p122RhoGAP (deleted in liver cancer-1) Serine 322 as a substrate for protein kinase B and ribosomal S6 kinase in insulin-stimulated cells - PubMed (original) (raw)

• Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.
  Tripathi BK, Grant T, Qian X, Zhou M, Mertins P, Wang D, Papageorge AG, Tarasov SG, Hunter KW, Carr SA, Lowy DR. Tripathi BK, et al. J Cell Biol. 2017 Dec 4;216(12):4255-4270. doi: 10.1083/jcb.201703105. Epub 2017 Nov 7. J Cell Biol. 2017. PMID: 29114068 Free PMC article.
• Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review).
  Zimonjic DB, Popescu NC. Zimonjic DB, et al. Int J Oncol. 2012 Aug;41(2):393-406. doi: 10.3892/ijo.2012.1474. Epub 2012 May 10. Int J Oncol. 2012. PMID: 22580498 Free PMC article. Review.
• Loci for insulin processing and secretion provide insight into type 2 diabetes risk.
  Broadaway KA, Yin X, Williamson A, Parsons VA, Wilson EP, Moxley AH, Vadlamudi S, Varshney A, Jackson AU, Ahuja V, Bornstein SR, Corbin LJ, Delgado GE, Dwivedi OP, Fernandes Silva L, Frayling TM, Grallert H, Gustafsson S, Hakaste L, Hammar U, Herder C, Herrmann S, Højlund K, Hughes DA, Kleber ME, Lindgren CM, Liu CT, Luan J, Malmberg A, Moissl AP, Morris AP, Perakakis N, Peters A, Petrie JR, Roden M, Schwarz PEH, Sharma S, Silveira A, Strawbridge RJ, Tuomi T, Wood AR, Wu P, Zethelius B, Baldassarre D, Eriksson JG, Fall T, Florez JC, Fritsche A, Gigante B, Hamsten A, Kajantie E, Laakso M, Lahti J, Lawlor DA, Lind L, März W, Meigs JB, Sundström J, Timpson NJ, Wagner R, Walker M, Wareham NJ, Watkins H, Barroso I, O'Rahilly S, Grarup N, Parker SC, Boehnke M, Langenberg C, Wheeler E, Mohlke KL. Broadaway KA, et al. Am J Hum Genet. 2023 Feb 2;110(2):284-299. doi: 10.1016/j.ajhg.2023.01.002. Epub 2023 Jan 23. Am J Hum Genet. 2023. PMID: 36693378 Free PMC article.
• Mutations in the focal adhesion targeting region of deleted in liver cancer-1 attenuate their expression and function.
  Liao YC, Shih YP, Lo SH. Liao YC, et al. Cancer Res. 2008 Oct 1;68(19):7718-22. doi: 10.1158/0008-5472.CAN-08-2042. Cancer Res. 2008. PMID: 18829524 Free PMC article.
• DLC-1:a Rho GTPase-activating protein and tumour suppressor.
  Durkin ME, Yuan BZ, Zhou X, Zimonjic DB, Lowy DR, Thorgeirsson SS, Popescu NC. Durkin ME, et al. J Cell Mol Med. 2007 Sep-Oct;11(5):1185-207. doi: 10.1111/j.1582-4934.2007.00098.x. J Cell Mol Med. 2007. PMID: 17979893 Free PMC article. Review.